These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1431129)

  • 1. CD4 changes conformation upon ligand binding.
    Szabò G; Pine PS; Weaver JL; Rao PE; Aszalos A
    J Immunol; 1992 Dec; 149(11):3596-604. PubMed ID: 1431129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY; Hariharan K; Posner MR; Nara P
    J Immunol; 1993 Jul; 151(1):449-57. PubMed ID: 7686944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of a polyanion binding site in mammalian and avian CD4.
    Parish CR; Warren HS
    Immunology; 1991 Oct; 74(2):191-6. PubMed ID: 1748468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule.
    Yachou A; Sékaly RP
    Biochem Biophys Res Commun; 1999 Nov; 265(2):428-33. PubMed ID: 10558884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
    Parish CR; Low L; Warren HS; Cunningham AL
    J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
    Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
    Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific disengagement of cell-bound anti-LAM-1 (anti-L-selectin) antibodies by aurintricarboxylic acid.
    Szabó G; Weaver JL; Pine PS; Aszalos A
    Mol Immunol; 1993 Dec; 30(18):1689-94. PubMed ID: 7505884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120.
    Denisova G; Raviv D; Mondor I; Sattentau QJ; Gershoni JM
    J Immunol; 1997 Feb; 158(3):1157-64. PubMed ID: 9013955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
    Gabriel JL; Mitchell WM
    Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
    Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
    J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recognition of chimeras of rat and human CD4 by HIV-1 gp120 and by monoclonal antibodies.
    Davis SJ; James WS; Schockmel GA; Simon JH; Somoza C
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):75-81. PubMed ID: 7904351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
    Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
    J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
    Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
    J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
    Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
    J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
    Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.